Factor VIII haplotypes frequencies in Tunisian hemophiliacs A

BACKGROUND: The development of inhibitors against factor 8 (F8) is the most serious complication of replacement therapy with F8 in children with severe hemophilia. It was suggested that mismatched F8 replacement therapy may be a risk factor for the development of anti-factor F8 alloantibodies. Recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmahmoudi, Hejer, Belhedi, Nejla, Jlizi, Asma, Zahra, Kaouther, Meddeb, Balkis, Elgaaied, Amel Ben Ammar, Gouider, Emna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148954/
https://www.ncbi.nlm.nih.gov/pubmed/21682900
http://dx.doi.org/10.1186/1746-1596-6-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148954/
https://www.ncbi.nlm.nih.gov/pubmed/21682900
http://dx.doi.org/10.1186/1746-1596-6-54

Ejemplares similares